KRISTINA HULTEN to Serogroup
This is a "connection" page, showing publications KRISTINA HULTEN has written about Serogroup.
Connection Strength
1.844
-
Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage. Emerg Infect Dis. 2018 02; 24(2):405.
Score: 0.634
-
Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States. J Clin Microbiol. 2017 03; 55(3):724-734.
Score: 0.582
-
Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):249-252.
Score: 0.164
-
The changing epidemiology of pneumococcal diseases. Lancet Infect Dis. 2018 09; 18(9):929-930.
Score: 0.164
-
Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
Score: 0.126
-
International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease. Vaccine. 2022 02 11; 40(7):1054-1060.
Score: 0.052
-
Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates. Microb Genom. 2020 05; 6(5).
Score: 0.046
-
Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017. Pediatrics. 2019 09; 144(3).
Score: 0.044
-
Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015 May 01; 60(9):1339-45.
Score: 0.032